CTSO - יחס חוב להיוון בספרים cytosorbents.com

The debt-to-market capitalization ratio generated by GURU.Markets quotes currently holds the status of 0.00. This price action confirms the leadership of Cytosorbents (CTSO) in the sorption systems niche, which allows the company to avoid dumping. Revenues are based on the supply of disposable cartridges to surgical centers for the treatment of sepsis. Stable demand is ensured through physician training, transforming consumables into a reliable cash cow.

This indicator reflects the proportion of borrowed funds relative to the company's equity. Analyzing this ratio allows an investor to assess financial stability and the risk of excessive debt load. The trend on the total debt-to-equity chart helps identify dangerous asset overvaluation in a timely manner. For Cytosorbents (CTSO), this balance is critical when financing expansion into the US market. Debt optimization will secure the resources necessary for the certification of new blood purification systems.